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Clockwise from top left: Zanvil Cohn and Ralph; Ralph, Anne O’Garra, and Jacques Banchereau at
a Keystone Conference they co-organized; Yong-Jun Liu telling Ralph of his exciting discovery of the plas-
macytoid DC; Claudia, Ralph Steinman’s wife, together with Kayo Inaba, Michel Nussenzweig, and Ralph
at one of the many immunology conferences Claudia attended; Ralph surveying numerous dendritic cells
at the Tsukigi Fish Market, Tokyo. Middle: M. Nussennzweig, K. Inaba, and W. van Voorhis.Ralph Steinman discovered dendritic
cells (DCs) in 1973 with Zanvil Cohn. He
went on to convince the world by his
work that DCs are unique cell types of
the immune system fundamental in initi-
ating and regulating immune responses
at large. Ralph Steinman had no compet-
itors in science, only collaborators—to his
way of thinking, the problem was bigger
than the ego. He inspired numerous
young people worldwide to further ex-
plore the mysteries underlying the funda-
mental functions of DCs. He encouraged
many to attempt to harness DC biology
for the improvement of the health of
mankind.
Ralph Steinman, a Canadian, received
his undergraduate degree from McGill
University in 1963 and his M.D. from
Harvard Medical School in 1968. After
an internship and residency at Massachu-
setts General Hospital, he joined the
Rockefeller University in 1970 as a post-
doctoral researcher in the Laboratory
of Cellular Physiology and Immunology
working with Zanvil Cohn, during which
time he discovered the dendritic cell.
Ralph was then appointed as an assistant
professor in 1972 and a professor in
1988. In 1995, he was named the Henry
G. Kunkel Professor, and in 1998 he was
appointed director of the Christopher
H. Browne Center for Immunology and
Immune Diseases. At the Rockefeller
University, Ralph trained numerous young
researchers who have gone on to become
eminent international scientists in their
own right. Claudia, Ralph’s wonderful
wife, was part of the scientific community
even though she herself is not a scientist.
Claudia traveled with Ralph to confer-
ences all over the world and is a friend
to many immunologists, having been a
radiant presence in Ralph’s life.
Ralph’s first papers generated a spirited
debate and many thought DCs were too
rare to make a difference. Ralph designed
a protocol to purify DCs from mouse
spleen, fractions which yielded small
numbers of DCs —but were they potent!
Together with Michel Nussenzweig,
Kayo Inaba, and Wesley van Voorhis,
Ralph showed that DCs stimulate MHC
restricted cytotoxic T cell responses
(MCN), can induce anti-tumor immunityin vivo (KI), and exist in humans (WVV).
At the same time, Ira Mellman worked
with Ralph on endocytosis, which led to
a close collaboration to reveal the cell bio-
logical basis of DC maturation. Gerold
Schuler joined Ralph’s laboratory some
time after this and demonstrated that
Langerhans cells are immature, but upon
culture matured to be able to stimulate
T cells. Nikolas Romani then joined Ralph
to show that immature Langerhans cells
take up protein antigens and process
them to activate T cells, losing this
capacity upon maturation.
Realizing that DCs are a critical compo-
nent in the immune response, Ralph’s lab
made a major effort to isolate cell-specific
markers leading to the production of theImmunity 35, Nmonoclonal antibody N418, which recog-
nizes CD11c, opening up possibilities for
purifying these important cells. Although
they were extremely potent at stimulating
immune responses, DCs represented a
tiny number of cells within lymphoid
organs. A major breakthrough, which
opened up the field for the immunology
world at large, was the ability to grow
DCs in vitro. Kayo Inaba and Ralph pub-
lished a seminal paper showing that they
could culture DCs from mouse bone
marrow using the cytokine GM-CSF in
the Journal of Experimental Medicine
(JEM) in 1992. At the same time, Christo-
phe Caux, Jacques Banchereau, and
colleagues published a paper in Nature
showing that the cytokines GM-CSF andovember 23, 2011 ª2011 Elsevier Inc. 651
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human dendritic Langerhans cells. Ralph,
Kayo Inaba, Gerold Schuler, Jacques
Banchereau, Federica Sallusto, and Anto-
nio Lanzavecchia pioneered techniques
to grow DCs, eliminating the arduous
task of purifying them from lymphoid
organs. This work set the stage for current
research on the regulation of DC function
and the design of DC-based vaccines for
HIV and cancers. The DC field exploded
at that time and we all remember how
Ralph was excited to welcome new-
comers to the DC field. As Jacques remi-
nisces: ‘‘Ralph became a friend of the
Institute in Dardilly near Lyon and came
to advise us on our emerging dendritic
cell program which included the
sequencing of mRNA transcripts with
Gerard Zurawski at DNAX. To Ralph’s
joy, a quarter of the transcripts were
unknown. The Lyon visits also revealed
Ralph’s best-kept secret: his love of
food and wine! This started the tradition
of the Keystone Dendritic Cell meetings
which is still vibrant to these days.’’
Ralph was not only a brilliant scientist
but also a most generous person whose
devotion to the scientific community was
unprecedented. He was an advocate for
human immunology research, and Ralph
pushed us into writing grants to test DCs
in patients with cancer. Writing these
hundreds of pages was not easy given
that much of the funwas in the conception
of these protocols, but Ralph would break
up the monotony by teaching us salsa
dancing! Naturally, injecting DCs to our
first patients was a relief after all this
protocol writing and brought a lot of
hope from both the patients and the
doctors. One of Banchereau’s colleagues,
Virginia Pascual recalls, ‘‘Ralph was
always so excited to see our findings that
dendritic cells were playing such an
important role in the pathogenesis of
autoimmune diseases in children, and
encouraged us strongly to find ways to
harness them towards therapy,’’ whereas
another, Karolina Palucka, remembers
Ralph said, ‘‘it is important that you put
your talents to study dendritic cells and
use them in your treatment of disease.’’
Gerold Schuler recounts, ‘‘In 1990, Ralph
advised me to join his lab for a sabbatical
just to overcome some personal problems
at home by doing science at Rockefeller.
Surprisingly, this short stay not only652 Immunity 35, November 23, 2011 ª2011helped me to find my balance again but
as a side effect also led to the first repro-
ducible method to generate human
dendritic cells from hematopoietic precur-
sors .’’ Anne O’Garra remembers how
thrilled Ralph was when she told him that
she was starting to work on the immune
responses in tuberculosis: ‘‘Ralph re-
vealed to me that the Dana Foundation
was looking to fund basic researchers
moving into human immunology and
disease research—this launched our way
forward.’’ Madhav Dhodapkar, a clinical
researcherwhoworked closelywith Ralph
for a decade on human immunology re-
search with a focus on myeloma, shares
his experiences with Ralph as follows:
‘‘Ralph was a true champion for human
immunology and really believed in the
power of making discoveries directly in
patients.’’
Ralph’s devotion to the scientific
community was obvious to all, with self-
less contributions tomany through behind
the scenes activities, for example, sitting
on many scientific advisory boards, as
always with the motive to support and
encourage great science. He was trustee
of the Trudeau Institute, in Saranac Lake,
NY, and served as a scientific advisor
to several organizations including the
Charles A. Dana Foundation; a European
consortium on the development of HIV
vaccines; Jacques’s Baylor Institute for
Immunology Research in Dallas; the
Campbell Family Institute of Breast
Cancer Research in Toronto, Canada;
the M. D. Anderson Cancer Center for
Immunology Research in Houston, TX;
the RIKEN Center for Allergy and Immu-
nology Research in Yokohama, Japan;
and the CHAVI Center for HIV AIDS
Vaccine Immunology, Durham, NC. Ralph
wasalsoamemberof a numberof editorial
boards. Ralph joined the editorial board of
JEM in 1978 and was totally devoted to
the journal. He showed diligence in his
editorial work that was an example to us
all. Ralph was always hunting out novel
findings at conferences, encouraging
young people to pursue their findings
and encouraging their submission to JEM
in a professional but caring way. Ralph
would spend timewith young researchers,
studying their posters in depth at confer-
ences and advising on how they should
spell out their novel findings when submit-
ting their findings for publication.Elsevier Inc.The work of Ralph and his colleagues
has received worldwide recognition.
Ralph received the AlbanyMedical Center
Prize in Medicine and Biomedical Re-
search in 2009, the Albert Lasker Basic
Medical Research Award in 2007, the
New York City Mayor’s Award for Excel-
lence in Science and Technology in
2004, and the Gairdner Foundation Inter-
national Award in 2003. He is also a recip-
ient of Freidrich-Sasse, Emil von Behring,
and Robert Koch Prizes, the Rudolf
Virchow and Coley Medals, and the De-
brecen Award in Molecular Medicine and
has been awarded honorary degrees
from the University of Innsbruck, Free
University of Brussels, Erlangen Univer-
sity, and the Mount Sinai School of Medi-
cine. He was a corresponding fellow of
the Royal Society of Edinburgh and a
member of the National Academy of
Sciences and its Institute of Medicine.
Perhaps the pinnacle of these awards is
the Nobel Prize for Physiology or Medi-
cine in 2011. Sadly, Ralph passed away
on the September 30, 2011, after battling
with pancreatic cancer for four and a half
years. Ralph was passionately involved in
science until the last days of his life.
Although we are all in mourning,
Ralph’s presence will always be with us
at dendritic cell meetings, at immunology
meetings at large, and in our labs and
in our hearts. We feel privileged to have
interacted so closely with Ralph through-
out all these years and to have benefited
from his wisdom, generosity, and enthu-
siasm for science.Anne O’Garra,1,*
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